Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.25+0.68 (+4.10%)
At close: 04:00PM EDT
16.99 -0.26 (-1.51%)
After hours: 07:00PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • D
    DavidGB£
    Pulling up the chart on the daily we can see the old highs in December 21 are acting as strong support. We are punching between the $16 and change support and research resistance in the $17 area. Once we crack that, next is $20. Then we close the gap above. Once we do that I expect the tailwinds to be significant and a run up to the old highs for a continuous of the cup formation. Probably a buyout around then at a nice premium
    Bullish
  • M
    Michael
    Extremely impressive momentum since the E.R. & webcast
    Bullish
  • e
    ed
    I was a long time Kite investor. I must say I made a bundle. About 1 year prior to the buyout Kite did an secondary offering to raise money. It diluted shares by about 10%. It did not matter. Gilead bought it for about 12 billion. Allo will sell for the same if not more. They have already shown that their allogenic drug works as well but has many more obvious advantages.

    I think minimal sale price will be $100/share.
  • M
    MS
    ALLO price target soon will be $55-$60
    Bullish
  • D
    DavidGB£
    U.S. FDA Clearance on Potential Pivotal Phase 2 Trial of ALLO-501A Anticipated in Coming Weeks
    Expected to be the Industry’s First Allogeneic CAR T Phase 2 Pivotal Trial
    Clearance to Cover ALPHA2 Protocol and Chemistry Manufacturing and Controls (CMC) for Use of ALLO-501A Manufactured from Cell Forge 1 (CF1)
    CF1 is Projected to Support the Manufacture of ~20,000 Doses of AlloCAR T™ Products Annually at Scale
    Bullish
  • D
    DavidGB£
    These guys sold Kite Pharma for 12bn, and this company is the Ford of T cell therapy. This is for mass production of this treatment. I won't be surprised for a buyout closer to 20bn this time around. Lightning in a bottle.
    Bullish
  • D
    DavidGB£
    Also if you like technicals a golden Cross will form tomorrow so trader's will have their interest peaked.

    50 day crossing the 200 day moving average
    Bullish
  • m
    mr.m
    looking very good
  • M
    Mitch
    in Q2 2022 Gilead reported $295mil in sales of Yescarta primarily driven by demand for relapsed or refractory (“R/R”) large B-cell lymphoma (“LBCL”) in the United States and Europe and R/R follicular lymphoma (“FL”) in the United States.

    Lead product from Kite pipeline which Gilead acquired in 2017.
  • T
    Terminal Gravity
    Heavy short interest. They must be hating life right now with this move to higher highs and news coming. Accumulating.
    Bullish
  • f
    frank
    Ripping
    Bullish
  • M
    MS
    In her coverage for Goldman, 5-star analyst Salveen Richter points out the key upcoming catalysts here, writing, “…we anticipate a period of execution on lead allogeneic CAR T programs ALLO-501A (anti-CD-19) … where FDA alignment on and initiation of the pivotal trials in mid-22 pave a path toward approval, and ALLO-715 (anti-BCMA) … where clarity on the forward path is expected by YE22 per longer-term follow-up monotherapy data… Separately, we note first data from the Ph1 ALLO-316 TRAVERSE study in renal cell carcinoma in 2023 could unlock the solid tumor vertical.”
  • S
    SuperRadDad
    When this gets the phase 2 go ahead in the next couple weeks it’s going way up quick.
  • M
    MS
    Good morning ALLO share holders 16 on 8/8
  • f
    frank
    On fire again
    Bullish
  • T
    Tom
    Shorts are covering buying and whales are selling. Wait till the big drop. You havent exp. this before?
  • S
    SuperRadDad
    Lol! Tom the short has been silent since our rise! One day the whole market goes down except oil he’s back. With his scare tactics. Aren’t you broke shorting this yet? This will be $25 very soon.
    Bullish
  • S
    SuperRadDad
    Hold and buy here. This is going to rebound. Volume only 45000 right now. Good buying opportunity if your quick.
  • m
    mr.m
    That's a nice morning rise i guess there is some positive anticipation in the air
  • T
    Tom
    If this goes to $19 I will give SuperRad $50K if this goes down to $11 SuperRad you pay me $25K. Price delta and bet are in your favor how about. Buy your wife something nice.
Advertisement
Advertisement